Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: Tesamorelin + Ipamorelin evidence and protocol review
Also known as: Tesa/IPA
This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.
Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.
Tesamorelin + Ipamorelin combines Tesamorelin + Ipamorelin into a single research protocol. Each component is independently studied; this entry summarizes the individual evidence base for the combination, since no unified safety/efficacy dataset covers the mixed formulation unless noted below. Tesamorelin: GHRH analog FDA-approved as Egrifta/Egrifta SV/Egrifta WR for reduction of excess abdominal fat in HIV-associated lipodystrophy. Ipamorelin: Pentapeptide ghrelin-receptor (GHS-R1a) agonist with the cleanest selectivity in its class - GH release without significant cortisol, ACTH, or prolactin stimulation. This is a community-stacking combination assembled from two independently studied compounds rather than a pharmaceutical sponsor's dedicated fixed-dose combination program - no dedicated human combination trial exists for this exact pairing as of this writing.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Evidence for individual components does not validate the exact mixed formulation. Component amounts, ratios, compatibility, sterility, and stability must be documented.
Supplementary research context only. Not medical advice or a treatment recommendation.
Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.
Community dosing guides describe Tesamorelin as having actual FDA-approved dosing context (1.28-2 mg daily) for visceral fat/GH-axis support -- notably better-established than most research peptides -- while Ipamorelin (200-300 mcg 1-2x daily) is described as a common recovery/sleep add-on. A real user thread shows someone stacking a high-dose Tesamorelin (15mg) with a CJC/Ipamorelin blend and TRT, which the community flagged as excessive and likely responsible for reported water retention. Anecdotal only.
undefined
Widely-referenced community dosing/cycle reference guide covering GH-secretagogue stacks; crowd-sourced compilation, not clinically verified.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention Tesamorelin + Ipamorelin or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.